Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
AGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAG| |GTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTC
End
32973452/32973346 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/578871; hsa-mir-103a-1/Downstream/3174546;
Upstream sequence
catgcctgacTCCAAATGAGAAAGTTTAATGCTGATCATTTGTACAATGGCTGGGGCACATTTATGGGCAGTTGAAATTCATTTAAAGAACTTCTTATAG
Downstream sequence
CTACTGTGGAGACCTAGTATCATGACAGCTCATAACCAGAATATAAATGTGACATTTGACCTAGTGATCTTTTCTGAATCAAACTTTCTCTTTCAGCAGC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.